Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Laxdale Limited

Psychiatric and CNS diseases, including schizophrenia, bipolar disorders, depression and alzheimer's disease.


Contact Details:
Kings Park House, Laurelhill Business Park
Sterling
Scotland
FK7 9JQ
United Kingdom
Tel:01786 476 001
Fax:01786 473 137
Email:admin@laxdale.co.uk
WWW:

www.laxdale.co.uk/




Loading...

Recent Publications by Laxdale Limited:

Ethyl-eicosapentaenoate and dexamethasone resistance in therapy-refractory depression.
Preliminary evidence shows that ethyl-eicosapentaenoate (E-EPA) has a...
28th October, 2004
Laxdale Ltd, Int J Neuropsychopharmacol. 2004 Sep;7(3):341-9. Epub 2004 Mar 5.
DOI Direct Link
The renin-angiotensin-aldosterone system in patients with depression compared to controls--a sleep endocrine study.
BACKGROUND: Hypercortisolism as a sign of...
9th July, 2004
Max-Planck-Institute of Psychiatry, 80804 Munich, Germany. BMC Psychiatry. 2003 Oct 29;3:15.
DOI Direct Link
A low toxicity maintenance regime, using eicosapentaenoic acid and readily available drugs, for mantle cell lymphoma and other malignancies with excess cyclin D1 levels.
Mantle cell lymphoma is a difficult to treat non-Hodgkin's lymphoma (NHL)...
6th January, 2004
Laxdale Med Hypotheses. 2003 May;60(5):615-23.
The effects on plasma, red cell and platelet fatty acids of taking 12 g/day of ethyl-eicosapentaenoate for 16 months: dihomogammalinolenic, arachidonic and docosahexaenoic acids and relevance to Inuit metabolism.
A patient with mantle cell lymphoma took 12g/day of...
17th December, 2003
Laxdale Ltd, Kings Park House, Laurelhill Business Park, Stirling, FK7 Prostaglandins Leukot Essent Fatty Acids. 2003 May;68(5):301-4.
Why do we not make more medical use of nutritional knowledge? How an inadvertent alliance between reductionist scientists, holistic dietitians and drug-oriented regulators and governments has blocked progress.
BACKGROUND: Hypercortisolism as a sign of...
2nd August, 2003
Laxdale Ltd, Kings Park House, Laurelhill Business Park, Stirling FK7 9JQ, Br J Nutr. 2003 Jul;90(1):233-8.

View more Laxdale Limited research publications.

Laxdale Limited Clinical Trials:

Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants

Laxdale Limited Patents:

US Patent No.Title
7119118 Highly purified ethyl EPA and other EPA derivatives for treatment of huntington's disease
6919330 Formulations of drugs
6689812 Highly purified ethyl EPA and other EPA derivatives for psychiatric and neurological disorders
6479544 Therapeutic combinations of fatty acids
6441038 Treatment of fatigue, head injury and stroke

View more Laxdale Limited patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 788 times since April 2007, the link to the organisation's website has been followed 189 times

Recent Search Terms used to find this page: laxdale ltd | Laxdale Limited | laxdale ltd | Laxdale Limited | Laxdale ltd | Laxdale schizophrenia | laxdale ltd | Laxdale Ltd | Laxdale Limited EPA | Laxdale Ltd | .

Search for more companies in Sterling

Search for more companies in Scotland



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Laxdale Limited

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.